Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other financing activities (2019 - 2020)

Historic Other financing activities for Pliant Therapeutics (PLRX) over the last 2 years, with Q3 2020 value amounting to $3000.0.

  • Pliant Therapeutics' Other financing activities fell 5714.29% to $3000.0 in Q3 2020 from the same period last year, while for Sep 2022 it was $3000.0, marking a year-over-year decrease of 7272.73%. This contributed to the annual value of $150000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Pliant Therapeutics reported Other financing activities of $3000.0 as of Q3 2020, which was down 5714.29% from $1000.0 recorded in Q2 2020.
  • Over the past 5 years, Pliant Therapeutics' Other financing activities peaked at $7000.0 during Q3 2019, and registered a low of $1000.0 during Q2 2020.